EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis

Dirk Westhölter iD, Johannes Haubold iD, Matthias Welsner, Luca Salhöfer, Johannes Wienker, Sivagurunathan Sutharsan, Svenja Straßburg, Christian Taube, Lale Umutlu, Benedikt M Schaarschmidt, Sven Koitka, Sebastian Zensen und 4 weitere

Scientific Reports · 2024

DOI: 10.1038/s41598-024-59622-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Dirk Westhölter und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Essen, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Body Composition, Aminophenols, Quinolones. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A poor nutritional status is associated with worse pulmonary function and survival in people with cystic fibrosis (pwCF). CF transmembrane conductance regulator modulators can improve pulmonary function and body weight, but more data is needed to evaluate its effects on body composition. In this retrospective study, a pre-trained deep-learning network was used to perform a fully automated body composition analysis on chest CTs from 66 adult pwCF before and after receiving elexacaftor/tezacaftor/ivacaftor (ETI) therapy. Muscle and adipose tissues were quantified and divided by bone volume to obtain body size-adjusted ratios. After receiving ETI therapy, marked increases were observed in all adipose tissue ratios among pwCF, including the total adipose tissue ratio (+ 46.21%, p < 0.001). In contrast, only small, but statistically significant increases of the muscle ratio were measured in the overall study population (+ 1.63%, p = 0.008). Study participants who were initially categorized as underweight experienced more pronounced effects on total adipose tissue ratio (p = 0.002), while gains in muscle ratio were equally distributed across BMI categories (p = 0.832). Our findings suggest that ETI therapy primarily affects adipose tissues, not muscle tissue, in adults with CF. These effects are primarily observed among pwCF who were initially underweight. Our findings may have implications for the future nutritional management of pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisBody CompositionAminophenolsQuinolonesBenzodioxolesDrug CombinationsIndolesQuinolinesHumansMaleAdultFemaleRetrospective StudiesPyrazolesPyridinesTomography, X-Ray ComputedYoung AdultPyrrolidinesCystic Fibrosis Transmembrane Conductance RegulatorAdipose TissueNutritional Status

Substanzen

AminophenolsQuinolonesBenzodioxolesDrug CombinationsIndolesPyrazolesPyridinesPyrrolidinesCystic Fibrosis Transmembrane Conductance Regulatorelexacaftor

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Essen, Germany.
  • Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
  • Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
  • Adult Cystic Fibrosis Center, Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Essen, Germany.
  • Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany. marcel.opitz@uk-essen.de.
  • Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany. marcel.opitz@uk-essen.de.

ORCID-Profile: Dirk Westhölter, Johannes Haubold

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Westhölter, D., Haubold, J., Welsner, M., Salhöfer, L., Wienker, J., Sutharsan, S., Straßburg, S., Taube, C., Umutlu, L., Schaarschmidt, B. M., Koitka, S., Zensen, S., Forsting, M., Nensa, F., Hosch, R., & Opitz, M. (2024). Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis. Scientific Reports. https://doi.org/10.1038/s41598-024-59622-2

Vancouver

Westhölter D, Haubold J, Welsner M, Salhöfer L, Wienker J, Sutharsan S, et al. Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis. Scientific Reports. 2024. doi:10.1038/s41598-024-59622-2

BibTeX
@article{Westhlter2024,
  author = {Westhölter, Dirk and Haubold, Johannes and Welsner, Matthias and Salhöfer, Luca and Wienker, Johannes and Sutharsan, Sivagurunathan and Straßburg, Svenja and Taube, Christian and Umutlu, Lale and Schaarschmidt, Benedikt M and Koitka, Sven and Zensen, Sebastian and Forsting, Michael and Nensa, Felix and Hosch, René and Opitz, Marcel},
  title = {Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-59622-2}
}
Kostenlos starten →